Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Wattanapat Hospital Trang PCL EV-to-EBITDA?
Wattanapat Hospital Trang PCLBKK:WPH-R +1.35%81 EV-to-EBITDA is 9.27 as of Aug. 26, 2026, which is 52% below its 10-year median of 19.25. GuruFocus rates BKK:WPH-R with a GF Score™ of 81/100 and a GF Value™ of ฿9.50 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 517 Healthcare Providers & Services companies, Wattanapat Hospital Trang PCL ranks better than 60.35% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Wattanapat Hospital Trang PCL's enterprise value is ฿5,660 Mil.
Wattanapat Hospital Trang PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ฿610 Mil. Therefore, Wattanapat Hospital Trang PCL's EV-to-EBITDA for today is 9.27.
The historical rank and industry rank for Wattanapat Hospital Trang PCL's EV-to-EBITDA or its related term are showing as below:
BKK:WPH-R'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.84 Med: 19.25 Max: 112.45
Current: 9.27
During the past 12 years, the highest EV-to-EBITDA of Wattanapat Hospital Trang PCL was 112.45. The lowest was 4.84. And the median was 19.25.
BKK:WPH-R's EV-to-EBITDA is ranked better than 60.35% of 517
companies
in the Healthcare Providers & Services industry
Industry Median: 10.63
vs BKK:WPH-R: 9.27
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Wattanapat Hospital Trang PCL's PE Ratio (TTM) for today is calculated as:
Wattanapat Hospital Trang PCL's share price for today is ฿5.82742.
Wattanapat Hospital Trang PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.494.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:WPH-R vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Wattanapat Hospital Trang PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wattanapat Hospital Trang PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wattanapat Hospital Trang PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Wattanapat Hospital Trang PCL's EV-to-EBITDA falls into.
Wattanapat Hospital Trang PCL's current Enterprise Value is ฿5,660 Mil.
Wattanapat Hospital Trang PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿610 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wattanapat Hospital Trang PCL (BKK:WPH-R) has a EV-to-EBITDA of 9.27 as of Aug. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wattanapat Hospital Trang PCL. This is 52% below median its historical median of 19.25. Over the past decade, Wattanapat Hospital Trang PCL's EV-to-EBITDA has ranged from 4.84 to 112.45. According to the industry distribution chart, Wattanapat Hospital Trang PCL ranks #205 out of 517 companies in the Healthcare Providers & Services industry, placing it in the top 39.7%.
Is Wattanapat Hospital Trang PCL's EV-to-EBITDA too high?
Wattanapat Hospital Trang PCL's current EV-to-EBITDA of 9.27 is 52% below median its 10-year median of 19.25. Over the past 10 years, this metric has ranged from a low of 4.84 to a high of 112.45. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.63. Wattanapat Hospital Trang PCL's value of 9.27 is 12.8% below this industry median. Based on the distribution chart, Wattanapat Hospital Trang PCL ranks #205 out of 517 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Wattanapat Hospital Trang PCL has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wattanapat Hospital Trang PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattanapat Hospital Trang PCL ranks #205 out of 517 companies for EV-to-EBITDA. This puts Wattanapat Hospital Trang PCL in the upper half of its industry. The industry median EV-to-EBITDA is 10.63. Wattanapat Hospital Trang PCL's value of 9.27 is 12.8% below this benchmark. Historically, Wattanapat Hospital Trang PCL's own EV-to-EBITDA has ranged from 4.84 to 112.45 over the past decade. While the company's 10-year median is 19.25 vs. the industry median of 10.63, Wattanapat Hospital Trang PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.63, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wattanapat Hospital Trang PCL's current EV-to-EBITDA of 9.27 is 12.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wattanapat Hospital Trang PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattanapat Hospital Trang PCL's current EV-to-EBITDA is 9.27, which is 52% below median its own 10-year median of 19.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattanapat Hospital Trang PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattanapat Hospital Trang PCL (BKK:WPH-R) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿9.50, compared to a current price of ฿5.83 — trading 38.7% below its estimated fair value. The current EV-to-EBITDA is 9.27, which is 52% below median its 10-year median of 19.25 and 12.8% below the Healthcare Providers & Services industry median of 10.63. Wattanapat Hospital Trang PCL's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Wattanapat Hospital Trang PCL (BKK:WPH-R), the current EV-to-EBITDA is 9.27 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wattanapat Hospital Trang PCL (BKK:WPH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Wattanapat Hospital Trang PCL stock appears to be undervalued.
The current stock price of ฿5.83 is trading 38.7% below its estimated GF Value™ of ฿9.50.
GuruFocus considers Wattanapat Hospital Trang PCL to be Significantly Undervalued.
Key valuation signals for BKK:WPH-R:
EV-to-EBITDA: 9.27 (52% below median its 10-year median of 19.25)
GF Value™: ฿9.50 vs. price of ฿5.83 (38.7% below fair value)
Industry Position: 12.8% below the Healthcare Providers & Services median (#205 of 517)
No single metric tells the full story. See the BKK:WPH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wattanapat Hospital Trang PCL Ltd is engaged in medical services. Its operations are carried on only in Thailand. The company offers a range of services including Orthopedic Clinic, Neurosurgery Clinic, Neurology and Brain Clinic, Surgical Clinic, Heart Clinic, Internal Medicine Clinic, Obstetrics and Gynecology Clinic, Gastrointestinal and Liver Clinic, Children's Clinic, Eye Clinic, ENT Clinic, Dental Clinic, Dermatology and Beauty Clinic, Health Promotion Center, Other Centers and Clinics.
81GF Score
Get the complete analysis for BKK:WPH-R
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:WPH-R has been successfully added to your 
